Hospital-Level NICU Capacity, Utilization, and 30-Day Outcomes in Texas.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
05 Feb 2024
Historique:
medline: 15 2 2024
pubmed: 14 2 2024
entrez: 14 2 2024
Statut: epublish

Résumé

Risk-adjusted neonatal intensive care unit (NICU) utilization and outcomes vary markedly across regions and hospitals. The causes of this variation are poorly understood. To assess the association of hospital-level NICU bed capacity with utilization and outcomes in newborn cohorts with differing levels of health risk. This population-based retrospective cohort study included all Medicaid-insured live births in Texas from 2010 to 2014 using linked vital records and maternal and newborn claims data. Participants were Medicaid-insured singleton live births (LBs) with birth weights of at least 400 g and gestational ages between 22 and 44 weeks. Newborns were grouped into 3 cohorts: very low birth weight (VLBW; <1500 g), late preterm (LPT; 34-36 weeks' gestation), and nonpreterm newborns (NPT; ≥37 weeks' gestation). Data analysis was conducted from January 2022 to October 2023. Hospital NICU capacity measured as reported NICU beds/100 LBs, adjusted (ie, allocated) for transfers. NICU admissions and special care days; inpatient mortality and 30-day postdischarge adverse events (ie, mortality, emergency department visit, admission, observation stay). The overall cohort of 874 280 single LBs included 9938 VLBW (5054 [50.9%] female; mean [SD] birth weight, 1028.9 [289.6] g; mean [SD] gestational age, 27.6 [2.6] wk), 63 160 LPT (33 684 [53.3%] female; mean [SD] birth weight, 2664.0 [409.4] g; mean [SD] gestational age, 35.4 [0.8] wk), and 801 182 NPT (407 977 [50.9%] female; mean [SD] birth weight, 3318.7 [383.4] g; mean [SD] gestational age, 38.9 [1.0] wk) LBs. Median (IQR) NICU capacity was 0.84 (0.57-1.30) allocated beds/100 LB/year. For VLBW newborns, NICU capacity was not associated with the risk of NICU admission or number of special care days. For LPT newborns, birth in hospitals with the highest compared with the lowest category of capacity was associated with a 17% higher risk of NICU admission (adjusted risk ratio [aRR], 1.17; 95% CI, 1.01-1.33). For NPT newborns, risk of NICU admission was 55% higher (aRR, 1.55; 95% CI, 1.22-1.97) in the highest- vs the lowest-capacity hospitals. The number of special care days for LPT and NPT newborns was 21% (aRR, 1.21; 95% CI,1.08-1.36) and 37% (aRR, 1.37; 95% CI, 1.08-1.74) higher in the highest vs lowest capacity hospitals, respectively. Among LPT and NPT newborns, NICU capacity was associated with higher inpatient mortality and 30-day postdischarge adverse events. In this cohort study of Medicaid-insured newborns in Texas, greater hospital NICU bed supply was associated with increased NICU utilization in newborns born LPT and NPT. Higher capacity was not associated with lower risk of adverse events. These findings raise important questions about how the NICU is used for newborns with lower risk.

Identifiants

pubmed: 38353952
pii: 2815072
doi: 10.1001/jamanetworkopen.2023.55982
pmc: PMC10867701
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2355982

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD101523
Pays : United States

Investigateurs

Kristen K Bronner (KK)
Youngran Kim (Y)
George Little (G)
Joseph Schulman (J)
Jordan Taylor (J)

Références

Pediatrics. 2014 May;133(5):844-53
pubmed: 24777216
JAMA Pediatr. 2015 Sep;169(9):855-62
pubmed: 26214387
JAMA. 2011 May 25;305(20):2096-104
pubmed: 21610242
Epidemiology. 2007 Nov;18(6):805-35
pubmed: 18049195
Ann Intern Med. 2003 Feb 18;138(4):288-98
pubmed: 12585826
Hosp Pediatr. 2023 Nov 1;13(11):992-1000
pubmed: 37818615
J Pediatr. 2019 Jun;209:44-51.e2
pubmed: 30955790
Ann Intern Med. 2003 Feb 18;138(4):273-87
pubmed: 12585825
J Perinatol. 2021 Mar;41(3):468-477
pubmed: 32801351
J Perinatol. 2023 Jun;43(6):787-795
pubmed: 36792685
Pediatrics. 2006 Dec;118(6):e1667-79
pubmed: 17116699
JAMA Netw Open. 2020 Jun 1;3(6):e205239
pubmed: 32556257
JAMA. 2011 Mar 16;305(11):1113-8
pubmed: 21406648
JAMA Pediatr. 2017 Mar 6;171(3):e164396
pubmed: 28068438
Hosp Pediatr. 2013 Jan;3(1):7-15
pubmed: 24319830
Health Aff (Millwood). 2010 Nov;29(11):2114-7
pubmed: 21041753
Pediatrics. 2001 Aug;108(2):426-31
pubmed: 11483810
JAMA Pediatr. 2018 Jan 1;172(1):17-23
pubmed: 29181499
Hosp Pediatr. 2016 May;6(5):255-60
pubmed: 27117951
Health Serv Res. 2017 Apr;52(2):634-655
pubmed: 27256769
Health Aff (Millwood). 2006 Mar-Apr;25(2):521-31
pubmed: 16522606
JAMA Pediatr. 2013 Jan;167(1):47-54
pubmed: 23403539
Health Aff (Millwood). 2011 Feb;30(2):219-27
pubmed: 21289342
Am Econ J Econ Policy. 2016 May 1;8(2):154-185
pubmed: 27942353
Pediatrics. 2016 Mar;137(3):e20144210
pubmed: 26908663
BMJ. 2013 Feb 21;346:f549
pubmed: 23430282
J Am Heart Assoc. 2014 May 20;3(3):e000714
pubmed: 24847032
JAMA Netw Open. 2022 Jun 1;5(6):e2215596
pubmed: 35666499
Med Care. 2023 Nov 1;61(11):729-736
pubmed: 37449856
J Pediatr. 2018 Jan;192:73-79.e4
pubmed: 28969888
Eff Clin Pract. 2001 Jul-Aug;4(4):143-9
pubmed: 11525100
N Engl J Med. 2008 Apr 17;358(16):1658-61
pubmed: 18420498
PLoS One. 2013;8(2):e54900
pubmed: 23418432
J Pediatr. 2021 Sep;236:62-69.e3
pubmed: 33940013
Hosp Pediatr. 2020 Dec;10(12):1059-1067
pubmed: 33214138
Semin Perinatol. 2021 Apr;45(3):151395
pubmed: 33573773
Pediatrics. 2018 Nov;142(5):
pubmed: 30282782
JAMA Pediatr. 2023 Mar 1;177(3):278-285
pubmed: 36648939
Pediatrics. 2007 Feb;119(2):314-9
pubmed: 17272621
N Engl J Med. 2002 May 16;346(20):1538-44
pubmed: 12015393

Auteurs

David C Goodman (DC)

The Dartmouth Institute for Health Policy and Clinical Practice, Department of Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
The Children's Hospital at Dartmouth, Lebanon, New Hampshire.

Patrick Stuchlik (P)

The Dartmouth Institute for Health Policy and Clinical Practice, Department of Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.

Cecilia Ganduglia-Cazaban (C)

Center for Health Care Data and Department of Management, Policy, and Community Health, School of Public Health, The University of Texas Health Science Center at Houston.

Jon E Tyson (JE)

Institute for Clinical Research and Learning Health Care, McGovern Medical School at The University of Texas Health Science Center at Houston.

JoAnna Leyenaar (J)

The Dartmouth Institute for Health Policy and Clinical Practice, Department of Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
The Children's Hospital at Dartmouth, Lebanon, New Hampshire.

Elenir B C Avritscher (EBC)

Institute for Clinical Research and Learning Health Care, McGovern Medical School at The University of Texas Health Science Center at Houston.

Mathew Rysavy (M)

Institute for Clinical Research and Learning Health Care, McGovern Medical School at The University of Texas Health Science Center at Houston.

Kanekal S Gautham (KS)

Division of Neonatology, Department of Pediatrics, Nemours Children's Health, Orlando, Florida.

David Lynch (D)

The University of Texas at Austin.

Therese A Stukel (TA)

ICES, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH